Silence Therapeutics reported $93K in Loan Capital for its fiscal quarter ending in March of 2024.





Loan Capital Change Date
AstraZeneca USD 26.14B 19.58B Dec/2025
Autolus Therapeutics Ltd USD 251.94M 7.31M Sep/2025
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Novartis USD 29.59B 5.35B Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Silence Therapeutics USD 93K 0 Mar/2024